Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1208087-83-5 | MDL No. : | MFCD11040198 |
Formula : | C10H12ClN3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FHKSKATXLAGIAS-UHFFFAOYSA-N |
M.W : | 241.67 g/mol | Pubchem ID : | 45789847 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 63.07 |
TPSA : | 66.32 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.61 cm/s |
Log Po/w (iLOGP) : | 1.69 |
Log Po/w (XLOGP3) : | 1.64 |
Log Po/w (WLOGP) : | 1.05 |
Log Po/w (MLOGP) : | 0.97 |
Log Po/w (SILICOS-IT) : | 1.07 |
Consensus Log Po/w : | 1.28 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.52 |
Solubility : | 0.735 mg/ml ; 0.00304 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.65 |
Solubility : | 0.546 mg/ml ; 0.00226 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.14 |
Solubility : | 1.74 mg/ml ; 0.00719 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.35 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 86443-51-8 ]
2-Chloro-N-ethylpyrimidin-4-amine
Similarity: 0.70
[ 62968-37-0 ]
4-(2-Chloropyrimidin-4-yl)morpholine
Similarity: 0.69
[ 66131-68-8 ]
2-Chloro-N-methylpyrimidin-4-amine
Similarity: 0.69
[ 1820740-39-3 ]
2-Chloro-4-morpholinopyrimidine-5-carbaldehyde
Similarity: 0.67
[ 1192711-37-7 ]
2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid
Similarity: 0.65
[ 1334488-49-1 ]
1-(6-Methoxypyrimidin-4-yl)piperidine-4-carboxylic acid
Similarity: 0.74
[ 1192711-37-7 ]
2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid
Similarity: 0.65
[ 210962-09-7 ]
1-(Pyridin-4-yl)piperidine-4-carboxylic acid hydrochloride
Similarity: 0.63
[ 406476-31-1 ]
1-(5-(Trifluoromethyl)pyridin-2-yl)piperidine-4-carboxylic acid
Similarity: 0.60
[ 799283-92-4 ]
1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid
Similarity: 0.59
[ 1334488-49-1 ]
1-(6-Methoxypyrimidin-4-yl)piperidine-4-carboxylic acid
Similarity: 0.74
[ 7139-02-8 ]
2,6-Dichloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine
Similarity: 0.65
[ 210962-09-7 ]
1-(Pyridin-4-yl)piperidine-4-carboxylic acid hydrochloride
Similarity: 0.63
[ 1404192-13-7 ]
(1-(6-Ethoxypyrimidin-4-yl)piperidin-3-yl)methanol
Similarity: 0.62
[ 69206-89-9 ]
6-(Piperidin-1-yl)pyrimidin-4-amine
Similarity: 0.62
[ 1334488-49-1 ]
1-(6-Methoxypyrimidin-4-yl)piperidine-4-carboxylic acid
Similarity: 0.74
[ 86443-51-8 ]
2-Chloro-N-ethylpyrimidin-4-amine
Similarity: 0.70
[ 62968-37-0 ]
4-(2-Chloropyrimidin-4-yl)morpholine
Similarity: 0.69
[ 66131-68-8 ]
2-Chloro-N-methylpyrimidin-4-amine
Similarity: 0.69
[ 1820740-39-3 ]
2-Chloro-4-morpholinopyrimidine-5-carbaldehyde
Similarity: 0.67